{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,5,2]],"date-time":"2024-05-02T15:39:20Z","timestamp":1714664360259},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2011,2,17]],"date-time":"2011-02-17T00:00:00Z","timestamp":1297900800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Gastric Cancer"],"published-print":{"date-parts":[[2011,3]]},"DOI":"10.1007\/s10120-011-0011-y","type":"journal-article","created":{"date-parts":[[2011,2,16]],"date-time":"2011-02-16T20:34:04Z","timestamp":1297888444000},"page":"63-71","source":"Crossref","is-referenced-by-count":16,"title":["Adjuvant chemoradiation for resected gastric cancer: a 10-year experience"],"prefix":"10.1007","volume":"14","author":[{"given":"Amy T. Y.","family":"Chang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wai Tong","family":"Ng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ada L. Y.","family":"Law","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ki Man","family":"Ku","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael C. H.","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anne W. M.","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2011,2,17]]},"reference":[{"key":"11_CR1","unstructured":"Hong Kong Cancer Registry. Hong Kong Cancer Stat 2007. Hong Kong: Hospital Authority; 2009."},{"key":"11_CR2","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1002\/(SICI)1097-0142(20000215)88:4<921::AID-CNCR24>3.0.CO;2-S","volume":"88","author":"SA Hundahl","year":"2000","unstructured":"Hundahl SA, Phillips JL, Menck HR. The National Cancer Data Base Report on poor survival of U.S. gastric carcinoma patients treated with gastrectomy: Fifth Edition American Joint Committee on Cancer staging, proximal disease, and the \u201cdifferent disease\u201d hypothesis. Cancer. 2000;88:921\u201332.","journal-title":"Cancer"},{"key":"11_CR3","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1056\/NEJMoa055531","volume":"355","author":"D Cunningham","year":"2006","unstructured":"Cunningham D, Allum WH, Stenning SP, Thompson JN, Van de Velde CJ, Nicholson M, et al. Perioperative chemotherapy versus surgery alone for resectable gastroesophageal cancer. N Engl J Med. 2006;355:11\u201320.","journal-title":"N Engl J Med"},{"key":"11_CR4","doi-asserted-by":"crossref","first-page":"1810","DOI":"10.1056\/NEJMoa072252","volume":"357","author":"S Sakuramoto","year":"2007","unstructured":"Sakuramoto S, Sasako M, Yamaguchi T, Kinoshita T, Fujii M, Nashimoto A, et al. Adjuvant chemotherapy for gastric cancer with S-1, an oral fluoropyrimidine. N Engl J Med. 2007;357:1810\u201320.","journal-title":"N Engl J Med"},{"key":"11_CR5","first-page":"1178","volume":"12","author":"L Gianni","year":"2001","unstructured":"Gianni L, Panzini I, Tassinari D, Mianulli AM, Desiderio F, Ravaioli A, et al. Meta-analyses of randomized trials of adjuvant chemotherapy in gastric cancer. Ann Oncol. 2001;12:1178\u201380.","journal-title":"Ann Oncol"},{"key":"11_CR6","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1177\/030089160208800473","volume":"88","author":"I Panzini","year":"2002","unstructured":"Panzini I, Gianni L, Fattori PP, Tassinari D, Imola M, Fabbri P, et al. Adjuvant chemotherapy in gastric cancer: a meta-analysis of randomized trials and a comparison with previous meta-analyses. Tumori. 2002;88:21\u20137.","journal-title":"Tumori"},{"key":"11_CR7","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0360-3016(82)90377-7","volume":"8","author":"LL Gunderson","year":"1982","unstructured":"Gunderson LL, Sosin H. Adenocarcinoma of the stomach: areas of failure in a re-operation series (second or symptomatic look) clinicopathologic correlation and implications for adjuvant therapy. Int J Radiat Oncol Biol Phys. 1982;8:1\u201311.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"11_CR8","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1007\/s00066-007-7702-7","volume":"183","author":"G Klautke","year":"2007","unstructured":"Klautke G, Fietkau R. Significance of radiation therapy for adenocarcinomas of the esophagus, gastroesophageal junction and gastric cancer with special reference to the MAGIC trial. Strahlenther Onkol. 2007;183:163\u20139.","journal-title":"Strahlenther Onkol"},{"key":"11_CR9","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1016\/j.ctrv.2007.08.005","volume":"33","author":"F Fiorica","year":"2007","unstructured":"Fiorica F, Cartei F, Enea M, Licata A, Cabibbo G, Carau B, et al. The impact of radiotherapy on survival in resectable gastric carcinoma: a meta-analysis of literature data. Cancer Treat Rev. 2007;33:729\u201340.","journal-title":"Cancer Treat Rev"},{"key":"11_CR10","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/j.radonc.2009.06.014","volume":"92","author":"V Valentini","year":"2009","unstructured":"Valentini V, Cellini F, Minsky BD, Mattiucci GC, Balducci M, D\u2019Agostino G, et al. Survival after radiotherapy in gastric cancer: systematic review and meta-analysis. Radiother Oncol. 2009;92:176\u201383.","journal-title":"Radiother Oncol"},{"key":"11_CR11","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1056\/NEJMoa010187","volume":"345","author":"JS Macdonald","year":"2001","unstructured":"Macdonald JS, Smalley SR, Benedetti J, Hundahl SA, Estes NC, Stemmermann GN, et al. Chemoradiotherapy after surgery compared with surgery alone for adenocarcinoma of the stomach or gastroesophageal junction. N Engl J Med. 2001;345:725\u201330.","journal-title":"N Engl J Med"},{"key":"11_CR12","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/S0360-3016(01)02646-3","volume":"52","author":"SR Smalley","year":"2002","unstructured":"Smalley SR, Gunderson L, Tepper J, Martenson JA Jr, Minsky B, Willett C, et al. Gastric surgical adjuvant radiotherapy consensus report: rationale and treatment implementation. Int J Radiat Oncol Biol Phys. 2002;52:283\u201393.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"11_CR13","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.clon.2004.09.017","volume":"17","author":"J Ringash","year":"2005","unstructured":"Ringash J, Khaksart SJ, Oza A, Couture J, Japp B, Moore M, et al. Post-operative radiochemotherapy for gastric cancer: adoption and adaptation. Clin Oncol (R Coll Radiol). 2005;17:91\u20135.","journal-title":"Clin Oncol (R Coll Radiol)"},{"issue":"Suppl 1","key":"11_CR14","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1159\/000258494","volume":"77","author":"F Vita De","year":"2009","unstructured":"De Vita F, Vecchione L, Galizia G, Di Martino N, Fabozzi T, Catalano G, et al. Perspectives in adjuvant therapy of gastric cancer. Oncology. 2009;77(Suppl 1):38\u201342.","journal-title":"Oncology"},{"key":"11_CR15","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1016\/S0959-8049(99)00076-3","volume":"35","author":"CC Earle","year":"1999","unstructured":"Earle CC, Maroun JA. Adjuvant chemotherapy after curative resection for gastric cancer in non-Asian patients: revisiting a meta-analysis of randomised trials. Eur J Cancer. 1999;35:1059\u201364.","journal-title":"Eur J Cancer"},{"key":"11_CR16","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1023\/A:1008377101672","volume":"11","author":"E Mari","year":"2000","unstructured":"Mari E, Floriani I, Tinazzi A, Buda A, Belfiglio M, Valentini M, et al. Efficacy of adjuvant chemotherapy after curative resection for gastric cancer: a meta-analysis of published randomised trials. A study of the GISCAD (Gruppo Italiano per lo Studio dei Carcinomi dell\u2019Apparato Digerente). Ann Oncol. 2000;11:837\u201343.","journal-title":"Ann Oncol"},{"key":"11_CR17","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1080\/11024150201680005","volume":"168","author":"KG Janunger","year":"2002","unstructured":"Janunger KG, Hafstrom L, Glimelius B. Chemotherapy in gastric cancer: a review and updated meta-analysis. Eur J Surg. 2002;168:597\u2013608.","journal-title":"Eur J Surg"},{"key":"11_CR18","doi-asserted-by":"crossref","first-page":"6220","DOI":"10.1200\/JCO.2005.11.593","volume":"23","author":"L Lim","year":"2005","unstructured":"Lim L, Michael M, Mann GB, Leong T. Adjuvant therapy in gastric cancer. J Clin Oncol. 2005;23:6220\u201332.","journal-title":"J Clin Oncol"},{"key":"11_CR19","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1002\/jso.20223","volume":"90","author":"JS Macdonald","year":"2005","unstructured":"Macdonald JS. Role of post-operative chemoradiation in resected gastric cancer. J Surg Oncol. 2005;90:166\u201370.","journal-title":"J Surg Oncol"},{"key":"11_CR20","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1016\/j.ijrobp.2009.03.002","volume":"76","author":"KS May","year":"2010","unstructured":"May KS, Khushalani NI, Chandrasekhar R, Wilding GE, Iyer RV, Ma WW, et al. Analysis of clinical and dosimetric factors associated with change in renal function in patients with gastrointestinal malignancies after chemoradiation to the abdomen. Int J Radiat Oncol Biol Phys. 2010;76:1193\u20138.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"11_CR21","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1016\/j.ijrobp.2006.09.012","volume":"67","author":"EP Jansen","year":"2007","unstructured":"Jansen EP, Saunders MP, Boot H, Oppedijk V, Dubbelman R, Porritt B, et al. Prospective study on late renal toxicity following postoperative chemoradiotherapy in gastric cancer. Int J Radiat Oncol Biol Phys. 2007;67:781\u20135.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"11_CR22","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1016\/j.ijrobp.2005.05.005","volume":"63","author":"S Kim","year":"2005","unstructured":"Kim S, Lim DH, Lee J, Kang WK, MacDonald JS, Park CH, et al. An observational study suggesting clinical benefit for adjuvant postoperative chemoradiation in a population of over 500 cases after gastric resection with D2 nodal dissection for adenocarcinoma of the stomach. Int J Radiat Oncol Biol Phys. 2005;63:1279\u201385.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"11_CR23","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1097\/PPO.0b013e318178d23a","volume":"14","author":"CN Leong","year":"2008","unstructured":"Leong CN, Chung HT, Lee KM, Shakespeare TP, Mukherjee RK, Wong LC, et al. Outcomes of adjuvant chemoradiotherapy after a radical gastrectomy and a D2 node dissection for gastric adenocarcinoma. Cancer J. 2008;14:269\u201375.","journal-title":"Cancer J"},{"key":"11_CR24","doi-asserted-by":"crossref","first-page":"3773","DOI":"10.3748\/wjg.14.3773","volume":"14","author":"M Moehler","year":"2008","unstructured":"Moehler M, Lyros O, Gockel I, Galle PR, Lang H. Multidisciplinary management of gastric and gastroesophageal cancers. World J Gastroenterol. 2008;14:3773\u201380.","journal-title":"World J Gastroenterol"},{"key":"11_CR25","doi-asserted-by":"crossref","first-page":"1480","DOI":"10.1016\/S0959-8049(98)00201-9","volume":"34","author":"K Maruyama","year":"1998","unstructured":"Maruyama K, Sasako M, Kinoshita T, Sano T, Katai H, Hada M, et al. Should systematic lymph node dissection be recommended for gastric cancer? Eur J Cancer. 1998;34:1480\u20139.","journal-title":"Eur J Cancer"},{"key":"11_CR26","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/j.ejso.2003.11.020","volume":"30","author":"M Degiuli","year":"2004","unstructured":"Degiuli M, Sasako M, Calgaro M, Garino M, Rebecchi F, Mineccia M, et al. Morbidity and mortality after D1 and D2 gastrectomy for cancer: interim analysis of the Italian Gastric Cancer Study Group (IGCSG) randomised surgical trial. Eur J Surg Oncol. 2004;30:303\u20138.","journal-title":"Eur J Surg Oncol"},{"key":"11_CR27","doi-asserted-by":"crossref","unstructured":"Lee J, Kang W, Lim D, et al. Phase III trial of adjuvant capecitabine\/cisplatin (XP) versus capecitabine\/cisplatin\/RT (XPRT) in resected gastric cancer with D2 nodal dissection (ARTIST trial): safety analysis. J Clin Oncol 2009;27(15 Suppl):abstr 4537.","DOI":"10.1200\/jco.2009.27.15_suppl.4537"},{"key":"11_CR28","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1016\/j.ijrobp.2005.03.013","volume":"63","author":"J Ringash","year":"2005","unstructured":"Ringash J, Perkins G, Brierley J, Lockwood G, Islam M, Catton P, et al. IMRT for adjuvant radiation in gastric cancer: a preferred plan? Int J Radiat Oncol Biol Phys. 2005;63:732\u20138.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"11_CR29","doi-asserted-by":"crossref","first-page":"1236","DOI":"10.1016\/j.ijrobp.2004.02.051","volume":"59","author":"P Wieland","year":"2004","unstructured":"Wieland P, Dobler B, Mai S, Hermann B, Tiefenbacher U, Steil V, et al. IMRT for postoperative treatment of gastric cancer: covering large target volumes in the upper abdomen: a comparison of a step-and-shoot and an arc therapy approach. Int J Radiat Oncol Biol Phys. 2004;59:1236\u201344.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"11_CR30","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1259\/bjr\/43441736","volume":"79","author":"MT Milano","year":"2006","unstructured":"Milano MT, Garofalo MC, Chmura SJ, Farrey K, Rash C, Heimann R, et al. Intensity-modulated radiation therapy in the treatment of gastric cancer: early clinical outcome and dosimetric comparison with conventional techniques. Br J Radiol. 2006;79:497\u2013503.","journal-title":"Br J Radiol"},{"key":"11_CR31","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.ijrobp.2009.04.046","volume":"77","author":"B Wysocka","year":"2010","unstructured":"Wysocka B, Kassam Z, Lockwood G, Brierley J, Dawson LA, Buckley CA, et al. Interfraction and respiratory organ motion during conformal radiotherapy in gastric cancer. Int J Radiat Oncol Biol Phys. 2010;77:53\u20139.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"11_CR32","unstructured":"Randomized Phase III Trial of Adjuvant Chemotherapy or Chemoradiotherapy in Resectable Gastric Cancer (CRITICS). http:\/\/www.clinicaltrial.gov\/ct2\/show\/NCT00407186?term=CRITICS&rank=3 ."},{"key":"11_CR33","unstructured":"Chemotherapy and Radiation Therapy After Surgery in Treating Patients With Stomach or Esophageal Cancer (CALGB80101). http:\/\/www.clinicaltrial.gov\/ct2\/show\/NCT00052910?term=CALGB80101&rank=1 ."}],"container-title":["Gastric Cancer"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10120-011-0011-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10120-011-0011-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10120-011-0011-y","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,11,19]],"date-time":"2021-11-19T02:01:13Z","timestamp":1637287273000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10120-011-0011-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,2,17]]},"references-count":33,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2011,3]]}},"alternative-id":["11"],"URL":"https:\/\/doi.org\/10.1007\/s10120-011-0011-y","relation":{},"ISSN":["1436-3291","1436-3305"],"issn-type":[{"value":"1436-3291","type":"print"},{"value":"1436-3305","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,2,17]]}}}